simendan has been researched along with cytochrome c-t in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caimmi, PP; Cattaneo, M; Grossini, E; Mary, DA; Molinari, C; Platini, F; Tessitore, L; Uberti, F; Vacca, G; Valente, G | 1 |
| Angus, JA; Crack, PJ; Royse, CF; Soeding, PF; Wright, CE | 1 |
| Okada, M; Yamawaki, H | 1 |
3 other study(ies) available for simendan and cytochrome c-t
| Article | Year |
|---|---|
Modulation of programmed forms of cell death by intracoronary levosimendan during regional myocardial ischemia in anesthetized pigs.
Topics: Anesthesia; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; bcl-2-Associated X Protein; Blood Pressure; Cardiotonic Agents; Coronary Circulation; Cytochromes c; Gene Expression; Heart; Heart Rate; Hydrazones; In Situ Nick-End Labeling; Microtubule-Associated Proteins; Myocardial Ischemia; Myocardium; Necrosis; Proto-Oncogene Proteins c-bcl-2; Pyridazines; Simendan; Sus scrofa; Venous Pressure; Ventricular Function, Left | 2010 |
Levosimendan preserves the contractile responsiveness of hypoxic human myocardium via mitochondrial K(ATP) channel and potential pERK 1/2 activation.
Topics: Adrenergic beta-Agonists; Apoptosis; Caspase 3; Cell Hypoxia; Cytochromes c; Enzyme Activation; Heart Atria; Humans; Hydrazones; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isoproterenol; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle Contraction; Myocardium; Oxygen; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Potassium Channels; Proto-Oncogene Proteins c-akt; Pyridazines; Simendan | 2011 |
Levosimendan inhibits interleukin-1β-induced apoptosis through activation of Akt and inhibition of inducible nitric oxide synthase in rat cardiac fibroblasts.
Topics: Amidines; Animals; Apoptosis; Benzylamines; Chromones; Cytochromes c; Cytoprotection; Cytosol; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Gene Expression Regulation, Enzymologic; Hydrazones; Interleukin-1beta; Male; Morpholines; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Pyridazines; Rats; Rats, Wistar; Signal Transduction; Simendan | 2015 |